Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma

New England Journal of Medicine

Volumn 320, Issue 19, 1989, Pages 1244-1248

  Ollerenshaw, Suzanne ^a   Jarvis, Deborah ^b   Woolcock, Ann ^a   Sullivan, Colin ^a   Scheibner, Tethys ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ASTHMA; AUTOPSY; CONTROLLED STUDY; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0024598564     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198905113201904     Document Type: Article

References (16)

1. Polak JM, Bloom SR. Regulatory peptides and neuron-specific enolase in the respiratory tract of man and other animals. Exp Lung Res 1982; 3: 313–28.
2. Dey RD, Shannon WA Jr. Said SI. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res 1981; 220: 231–8.
3. VIP like immunoreactive nerves in human respiratory tract: light and electron microscopic study, A., Laitinen, M., Partanen, A., Hervonen, M., Pelto-Huikko, L.A., Laitinen, Histochemistry, (1985), 82, 313-319
4. Lundberg JM, Hokfelt T, Nilsonn G, et al. Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand 1979; 104: 499–501.
5. Saga T, Said SI. Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery and lung parenchyma. Trans Assoc Am Physicians 1984; 97: 304–10.
6. Coles SJ, Said SI, Reid LM. Inhibition by VIP of glycoconjugate and lysozyme secretion by human airways in vitro. Am Rev Respir Dis 1981; 124: 531–6.
7. Cameron AR, Hohnson CF, Kirkpatrick CT, Kirkpatrick MC. The quest for the inhibitory neurotransmitter in bovine tracheal smooth muscle. Q J Exp Physiol 1983; 68: 413–26.
8. Said SI. Influence of neuropeptides on airway smooth muscle. Am Rev Respir Dis 1987; 136: S52–S58.
9. Barnes PJ, Dixon CM. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis 1984; 130: 162–6.
10. Matsuzaki Y, Hamasaki Y, Said SI. Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways. Science 1980; 210: 1252–3.
11. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760–5.
12. Hsu SM, Raine L, Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80.
13. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984; 235: 251–61.
14. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27–33.
15. Barnes PJ. Neuropeptides in human airways: function and clinical implications. Am Rev Respir Dis 1987; 136: S77–S83.
16. Morice A, Unwin RJ, Sever PS. Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects. Lancet 1983; 2: 1225–7.